Enjoy Comparing 350 Kinds of Wine at Yamagata’s Winebal 2025 Festival, 10th Edition of Event Held
Visitors toast with wine in Kaminoyama, Yamagata Prefecture, on May 10.
16:44 JST, May 28, 2025
KAMINOYAMA, Yamagata — One of Japan’s largest wine festivals, Yamagata Winebal 2025, was held around Kaminoyama Castle in Kaminoyama, Yamagata Prefecture, on May 10 and 11. This year, a record number of 57 wineries opened stalls, with 27 coming from inside the prefecture and 30 from outside. Visitors enjoyed about 350 kinds of wines produced inside and outside the prefecture.
The event began in 2014 when a local commerce and industry organization formed an organizing committee, and this year was the 10th festival held, with a break for the COVID-19 pandemic.
At the festival, Kaminoyama-produced white wine with a refreshing fruity flavor, spicy red wine from Iwate Prefecture and aromatic rose wine with a slight sparkle were served, as well as grape juice that children could enjoy. Visitors received their wine into glasses after handing over the tickets they had purchased.
“The white wine was delicious with just a moderate acidity,” said Yumi Ishino, a 62-year-old pharmacist from Kawasaki. “It was a real luxury to be able to compare wines in the cool outdoors.”
Top Articles in Features
-
Tokyo’s New Record-Breaking Fountain Named ‘Tokyo Aqua Symphony’
-
High-Hydration Bread on the Rise, Seeing Increase in Specialty Shops, Recipe Searches
-
Japanese Students Use Traditional Pickle to Create Novel Wagashi Confectionery
-
Heirs to Kyoto Talent: Craftsman Works to Keep Tradition of ‘Kinran’ Brocade Alive Through Initiatives, New Creations
-
My Spendthrift Mother Constantly Asks Me for Money
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Videos Plagiarized, Reposted with False Subtitles Claiming ‘Ryukyu Belongs to China’; Anti-China False Information Also Posted in Japan
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

